(PDF) 072 IL-33 Affects Cytokine Profile in Psoriasis

072 IL-33 Affects Cytokine Profile in Psoriasis Inflammation in Imiquimod-Induced Psoriasis Model Mice

Journal of Investigative Dermatology - United Kingdom

doi 10.1016/j.jid.2019.03.148

Full Text

Abstract

Available in full text

Categories

Molecular Biology

Date

May 1, 2019

Authors

Publisher

Elsevier BV

Related search

Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice

Multidisciplinary

English

Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes

Journal of Investigative Dermatology

Molecular Biology

English

P093/O16 IL-36 Signaling in Keratinocytes Is Mandatory in Imiquimod-Induced Psoriasis in Mice

English

Blocking mTOR Signalling With Rapamycin Ameliorates Imiquimod-Induced Psoriasis in Mice

Acta Dermato-Venereologica

English

Ameliorating Effect of Oral Guggulsterone Administration in Imiquimod-Induced Psoriasis in Mice

Iraqi Journal of Pharmaceutical Sciences

Analytical Chemistry

English

459 HOIPIN-1, a Novel LUBAC Inhibitor, Suppresses the Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice

Journal of Investigative Dermatology

Molecular Biology

English

710 Tussilagonone Ameliorates Psoriatic Features in an Imiquimod-Induced Psoriasis-Like Dermatitis in Mice

Journal of Investigative Dermatology

Molecular Biology

English

061 Dextran-Based Mycophenolic Acid Nanoparticle Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation

Journal of Investigative Dermatology

Molecular Biology

English

1042 Characterizing Imiquimod (IMQ)-induced Psoriasis-Like Dermatitis in BALB/c Mice: Application in Dermatology Research

Journal of Investigative Dermatology

Molecular Biology

English